title: Clinical presentation and surgical outcomes in primary myopic macular hole retinal detachment.
abstract: OBJECTIVE
  To describe the clinical presentation of primary macular hole retinal detachment (MHRD) secondary to high myopia and to evaluate the surgical outcomes.
  
  
  METHODS
  Nine eyes of 9 patients with primary myopic MHRD (axial length =26.5 mm) were enrolled. A standardized surgical protocol was performed using vitrectomy with preservative-free triamcinolone acetonide-assisted internal limiting membrane (ILM) peeling and silicone oil tamponade and were followed for at least 6 months from the first surgery.
  
  
  RESULTS
  There were 6 women and 3 men with a median age of 52 years. Six (66.6%) patients presented with inferior bullous configuration and 3 had subtotal retinal detachment. The mean preoperative refractive error (spherical equivalent) and mean axial length was 12 ± 3.553 D (range 8.50-19.50) and 28.13 ± 1.65 mm (range 26.50-31.50), respectively. The patients were followed up for a period of at least 6 months. The retina was attached and macular hole closed in all the eyes. There was significant visual acuity improvement from mean preoperative visual acuity of logMAR 1.85 ± 0.11 (range 1.76-1.93) to postoperative visual acuity of logMAR 0.95 ± 0.14 (range 0.84-1.06) (p<0.001).
  
  
  CONCLUSIONS
  Retinal detachment in highly myopic eyes can often be secondary to a macular hole with predominance of inferior bullous configuration and primary vitrectomy with ILM peeling with silicone oil tamponade results in good anatomic and functional outcomes.
authors.affiliation: Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: Atul
authors.initials: A
authors.lastname: Kumar
authors.forename: Sana
authors.initials: S
authors.lastname: Tinwala
authors.forename: Varun
authors.initials: V
authors.lastname: Gogia
authors.forename: Subijay
authors.initials: S
authors.lastname: Sinha
mesh_terms: D000368:Aged; D058452:Axial Length, Eye; D001485:Basement Membrane / Q000473:pathology / Q000601:surgery; D058450:Endotamponade; D019773:Epiretinal Membrane / Q000175:diagnosis / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D047728:Myopia, Degenerative / Q000150:complications*; D012030:Refractive Errors / Q000503:physiopathology; D012163:Retinal Detachment / Q000209:etiology / Q000503:physiopathology / Q000601:surgery*; D012167:Retinal Perforations / Q000209:etiology / Q000503:physiopathology / Q000601:surgery*; D012827:Silicone Oils / Q000008:administration & dosage; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide; D014792:Visual Acuity / Q000502:physiology; D014821:Vitrectomy
chemical_list: D012827:Silicone Oils; D014222:Triamcinolone Acetonide